Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/DYADIC-INTERNATIONAL-INC-57599342/news/Dyadic-International-Inc-Provides-Phase-1-Clinical-Trial-Update-for-its-Recombinant-Protein-RBD-Va-44402280/?utm_source=whatsapp&utm_medium=social&utm_campaign=share